Login / Signup

Utilization and survival outcomes of neoadjuvant chemotherapy for early-stage gastric cancer.

Lauren M JanczewskiJoanna BuchheitRyan C JacobsDominic VitelloAmy WellsJohn AbadDavid J BentremAkhil Chawla
Published in: Journal of surgical oncology (2024)
Although patients who received NAT had more aggressive prognostic features, NAT was associated with worse OS despite accounting for this selection bias. These results highlight the importance of adhering to guidelines, regardless of differing disease characteristics, which has significant implications on outcomes.
Keyphrases
  • neoadjuvant chemotherapy
  • early stage
  • sentinel lymph node
  • locally advanced
  • lymph node
  • clinical practice
  • rectal cancer
  • squamous cell carcinoma
  • radiation therapy
  • type diabetes
  • adipose tissue
  • weight loss